The field of theranostics is growing rapidly as therapeutic regimes are increasingly being integrated and guided by diagnostic practices such as medical imaging. There is some room for discussion about the general definition of a theranostic agent, if there exists such a definition. Is it a diagnostic imaging agent that is used in the context to guide surgical procedures? Or rather, is it a the...

Genomic variation can lead to differential drug responses in individual patients, affecting drug absorption, metabolism, pharmacodynamics and excretion. Very often, polymorphisms in genes regulating these mechanisms are responsible for individual variability. The use of genome-wide association studies (GWAS) has enhanced the ability to identify such genetic variation, highlighting specific subg...

Aqueous conjugated polymer nanoparticles developed by nanoprecipitation from a quinoxaline–thiophene type with 3 fluorine atoms as potential cancer theranostics for breast cancer.

Nanomedicine research started exploring the combination of therapy and diagnostics, so-called theranostics, to offer a more flexible care with improved outcome. As magnetic nanoparticles show great potential in many diagnostic therapeutic applications, they are prime candidates be used theranostic setting. This perspective gives an overview state-of-the-art nanoparticle-based imaging techniques...